Hours

Minutes

Seconds

-40%

on all our subscriptions*

Spring Sale

Enjoy this offer

* See conditions under "Our services"

Valuation: Kwang Dong Pharmaceutical Co., Ltd.

Capitalization	230B 156M 135M 122M 116M 212M 14.36B 218M 1.44B 572M 6.87B 585M 572M 24.8B	P/E ratio 2023	8.14x	P/E ratio 2024	5.38x
Enterprise value	351B 237M 205M 185M 177M 322M 21.88B 332M 2.19B 871M 10.46B 891M 872M 37.78B	EV / Sales 2023	0.22x	EV / Sales 2024	0.21x
Free-Float	58.04%	Yield 2023	1.35%	Yield 2024	-

* Estimated data More valuation ratios

Chart: Kwang Dong Pharmaceutical Co., Ltd.

Timeframe

Style

Dynamic Chart

Latest news: Kwang Dong Pharmaceutical Co., Ltd.

Feb. 22	Kwang Dong Pharmaceutical Co., Ltd. announces Annual dividend	CI
Nov. 14	Kwang Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 05	Kwangdong Pharmaceutical Co., Ltd Announces Submission of New Drug Application for Brimochol?? PF for the Treatment of Presbyopia to the MFDS in South Korea	CI
Nov. 03	Kwangdong Healthbio Co., Ltd. announced that it has received KRW 3.058958 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
Nov. 03	Precision Biosensor, Inc. announced that it has received KRW 17.00000112 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
25-10-20	Kwangdong Pharmaceutical to divest 25 billion won worth of own shares	RE
25-10-16	Precision Biosensor, Inc. announced that it expects to receive KRW 17.00000112 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
25-10-14	Kwangdong Healthbio Co., Ltd. announced that it expects to receive KRW 3.058958 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	CI
25-09-29	Kwangdong Pharmaceutical to divest 22 billion won worth of own shares	RE
25-09-21	Kwang Dong Pharmaceutical Co., Ltd.(KOSE:A009290) dropped from S&P Global BMI Index	CI
25-08-14	Kwang Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Kwang Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-05-13	Kwangdong Pharmaceutical Q1 Operating Profit 3.3 Billion Won, Down 80.6% From Year Earlier	RE

More news

Managers and Directors: Kwang Dong Pharmaceutical Co., Ltd.

Manager	Title	Age	Since
Sung-Won Choi CEO	Chief Executive Officer	56	2013-07-29
Chae-Ju Lee PRN	Corporate Officer/Principal	53	2021-03-25
Sang-Young Park PRN	Corporate Officer/Principal	63	2011-08-24

Director	Title	Age	Since
Sung-Won Choi CHM	Chairman	56	-
Shin-Il Yeom BRD	Director/Board Member	52	2020-03-19
Sang-Young Park BRD	Director/Board Member	63	-

More insiders

Kwangdong Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company operates its business through five segments. The Mineral Water Business segment supplies drinking spring water under Samdasoo brand. The Distribution Business segment distributes health drinks under brand names of Vita500 and Corn Silk Tea. The Pharmacy Business segment provides Chinese prescription cold medicines, hypertension medicines, cerebral apoplexy medicines and health drinks. The Hospital Business segment offers anticancer agents, blood vessel adjuvants, vitamin D injections and others. The Other segment provides products which not covered by Pharmacy, Hospital and Distribution segments.

Employees

1,021

Sector

Pharmaceuticals

Calendar

Mar. 31 - Ex-dividend date - 100 KRW

More about the company

Quotes

Date	Price	Change	Volume
26-03-11	9,200.00 ₩	+0.99%	1,140,885
26-03-10	9,110.00 ₩	+3.17%	697,739
26-03-09	8,830.00 ₩	+0.11%	704,303
26-03-06	8,820.00 ₩	+6.78%	752,975
26-03-05	8,260.00 ₩	+8.26%	1,036,276

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. Other stock markets 2026-03-11			5-day change	1st Jan Change
9,200.00 ^KRW	+0.99%		+6.48%	+57.00%

1 day	+0.99%
1 week	+6.48%
Current month	-3.56%
1 month	+47.20%
3 months	+53.85%
6 months	+50.33%
Current year	+57.00%

1 week	7,780	9,860
1 month	6,020	12,800
Current year	5,640	12,800
1 year	5,110	12,800
3 years	5,010	12,800
5 years	5,010	12,800
10 years	3,910	13,350

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
KWANG DONG PHARMACEUTICAL CO., LTD.	+0.99%	+6.48%	+62.26%	+62.26%	228M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.72%	+4.19%	+13.30%	+91.08%	47.36B
OTSUKA HOLDINGS CO., LTD.	+6.77%	+7.35%	+47.21%	+169.11%	34.11B
SAM CHUN DANG PHARM. CO., LTD	-1.53%	+2.65%	+298.35%	+1,435.71%	12.47B
CIPLA LIMITED	-0.30%	-1.64%	-9.11%	+50.87%	11.73B
ZYDUS LIFESCIENCES LIMITED	-0.15%	+1.64%	+3.14%	+94.09%	10.11B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.59%	+12.02%	+79.93%	+56.17%	8.76B
KRKA, D. D.	0.00%	+6.48%	+36.50%	+116.98%	8.16B
ONO PHARMACEUTICAL CO., LTD.	-0.91%	-4.02%	+39.12%	-16.24%	7.18B
GLENMARK PHARMACEUTICALS LIMITED	+2.11%	+7.04%	+61.98%	+430.20%	6.84B
Average	+0.71%	+2.55%	+63.27%	+249.02%	14.69B
Weighted average by Cap.	+1.66%	+1.75%	+51.74%	+230.17%

	2023	2024
Net sales	1,514B 1.03B 886M 800M 765M 1.39B 94.5B 1.43B 9.45B 3.76B 45.19B 3.85B 3.76B 163B	1,641B 1.11B 960M 866M 829M 1.51B 102B 1.55B 10.24B 4.08B 48.96B 4.17B 4.08B 177B
Net income	36.97B 25.03M 21.62M 19.52M 18.67M 33.97M 2.31B 34.97M 231M 91.86M 1.1B 93.89M 91.9M 3.98B	40.48B 27.41M 23.68M 21.37M 20.44M 37.2M 2.53B 38.29M 253M 101M 1.21B 103M 101M 4.36B
Net Debt	29.46B 19.94M 17.23M 15.56M 14.88M 27.07M 1.84B 27.87M 184M 73.21M 879M 74.83M 73.24M 3.17B	120B 81.56M 70.48M 63.61M 60.84M 111M 7.52B 114M 752M 299M 3.6B 306M 299M 12.98B

Kwang Dong Pharmaceutical Co., Ltd. Stock

Equities

A009290

KR7009290008

Pharmaceuticals

Valuation: Kwang Dong Pharmaceutical Co., Ltd.

Chart: Kwang Dong Pharmaceutical Co., Ltd.

Latest news: Kwang Dong Pharmaceutical Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Kwang Dong Pharmaceutical Co., Ltd.

Generic Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates